These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 7475048)

  • 1. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme.
    Campbell DJ; Kladis A; Valentijn AJ
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):233-40. PubMed ID: 7475048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific regulation of angiotensin-converting enzyme by angiotensin II and losartan in the rat.
    Metsärinne KP; Helin KH; Saijonmaa O; Stewen P; Sirviö ML; Fyhrquist FY
    Blood Press; 1996 Nov; 5(6):363-70. PubMed ID: 8973755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload.
    Ishiye M; Umemura K; Uematsu T; Nakashima M
    Biol Pharm Bull; 1995 May; 18(5):700-4. PubMed ID: 7492986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
    Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of angiotensin in the dipsogenic effect of bradykinin in rats.
    Rowland NE; Fregly MJ
    Pharmacol Biochem Behav; 1997 Aug; 57(4):699-705. PubMed ID: 9258997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan increases bradykinin levels in hypertensive humans.
    Campbell DJ; Krum H; Esler MD
    Circulation; 2005 Jan; 111(3):315-20. PubMed ID: 15655136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
    Wada T; Inada Y; Ojima M; Sanada T; Shibouta Y; Nishikawa K
    Hypertens Res; 1996 Jun; 19(2):75-81. PubMed ID: 10968199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
    Campbell DJ; Kladis A; Duncan AM
    Hypertension; 1994 Apr; 23(4):439-49. PubMed ID: 8144213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
    Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
    Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
    Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive and hormonal activity of MK 954 in spontaneously hypertensive rats.
    Mizuno K; Niimura S; Tani M; Haga H; Gomibuchi T; Sanada H; Fukuchi S
    Eur J Pharmacol; 1992 May; 215(2-3):305-8. PubMed ID: 1396995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of responses to ANG IV: effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat.
    Nossaman BD; Feng CJ; Kaye AD; Kadowitz PJ
    Am J Physiol; 1995 Feb; 268(2 Pt 1):L302-8. PubMed ID: 7864150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
    Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
    Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II.
    Gorbea-Oppliger VJ; Fink GD
    J Pharmacol Exp Ther; 1995 May; 273(2):611-6. PubMed ID: 7752062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II.
    Gahnem F; Camargo MJ; von Lutterotti N; Laragh JH; Sealey JE
    J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
    Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive effects of losartan and enalapril on blood pressure and plasma active renin.
    Azizi M; Guyene TT; Chatellier G; Wargon M; Ménard J
    Hypertension; 1997 Feb; 29(2):634-40. PubMed ID: 9040450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.